2,4-Dinitrobenzenesulfonyl chloride, 98.0%, 25g

2-Nitro-5-(trifluoromethoxy)benzoic acid, 97.0%, 1g

4,4,5,5-Tetramethyl-2-(2-methyl-5-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane, 97%, 25g

2-Oxaspiro[3.3]heptan-6-ol, 95.0%, 1g

2-[(butylamino)methyl]phenol, 95.0%, 1g

1-(Cyclobutylmethyl)piperidin-4-amine dihydrochloride, 95.0%, 1g

4-Bromo-5-iodopyridin-2-amine, 95.0%, 25g

2-Amino-3-bromo-5-methylpyridine>98.0%(GC)5g

SRC KINASE INHIBITOR I, 95%, 50mg

(R)-2-(6-(Dicyclopentylmethyl)pyridin-2-yl)-4-phenyl-4,5-dihydrooxazole, 97%, 250mg

3-(5-Chlorothiophen-2-yl)-2-methylpropanoic acid, 98%, 1g

Methyl 3-[4-(tert-butoxycarbonyl)amino-piperidine-1-carbonyl]benzoate, 95.0%, 1g

3-(2-Chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxamide, 95.0%, 100mg